Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution

American Journal of Medicine

Volumn 120, Issue 7, 2007, Pages 636-642

  Moyssakis, Ioannis ^a   Tektonidou, Maria G ^b   Vasilliou, Vassilios A ^b   Samarkos, Michael ^b   Votteas, Vassilios ^a   Moutsopoulos, Haralampos M ^b  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antiphospholipid antibodies; Libman Sacks endocarditis; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; HUMAN; LIBMAN SACKS ENDOCARDITIS; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

ADULT; AGED; COHORT STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE;

EID: 34250902426     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.01.024     Document Type: Article

References (32)

1. Galve E., Candell-Riera J., Pigrau C., et al. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319 (1988) 817-823
2. Klinkhoff A.V., Thompson C.R., Reid G.D., and Tomlinson C.W. M-mode and two-dimensional echocardiography abnormalities in systemic lupus erythematosus. JAMA 253 (1985) 3273-3277
3. Doherty N., and Siegel R. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110 (1985) 1257-1265
4. Lopez J.A., Fishbein M.C., and Siegel R.J. Echocardiographic features of non-bacterial thrombotic endocarditis. Am J Cardiol 59 (1987) 478-480
5. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for classification of SLE. Arthritis Rheum 25 (1982) 1271-1272
6. Mosca M., Benvivelli W., Vitali C., et al. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 9 (2000) 445-450
7. Stoll T., Stucki G., Malik J., Pyke S., and Isenberg D.A. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 24 (1997) 309-313
8. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
9. Nihoyannopoulos P., Gomez P.M., Joshi J., et al. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 82 (1990) 369-375
10. Roldan C.A., Shively B.K., Lau C.C., et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 20 (1992) 1127-1134
11. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 18 (2003) 777-802
12. Otto C.M. Textbook of Clinical Echocardiography. 3rd edition. (2004), Elsevier Saunders, Philadelphia 277-311 315-350
13. Manousakis M.K., Gharavi A.E., Drosos A.A., et al. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 44 (1987) 297-307
14. Brigden W., Bywaters E.G.L., Lessof M.H., and Ross I.P. The heart in systemic lupus erythematosus. Br Heart J 22 (1960) 1-16
15. Ansari A., Larson P.H., and Bates H.D. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 27 (1985) 421-434
16. Straaton K., Chatham W., Reveille J., et al. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 86 (1989) 407-412
17. Cervera R., Font J., Pare C., et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51 (1992) 156-159
18. Gleason C., Stoddard M., Wagner S., et al. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 125 (1993) 1123-1129
19. Khamashta M.A., Cervera R., Asherson R.A., et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 335 (1990) 1541-1544
20. Asherson R.A., and Cervera R. Antiphospholipid antibodies and the heart: lessons and pitfalls for the cardiologist. Circulation 84 (1991) 920-922
21. McNeil H.P., Hunt J.E., and Krilis S.A. Antiphospholipid antibodies-new insights into their specificity and clinical importance. Scand J Immunol 36 (1992) 647-652
22. Chartash E., Lans D., Paget S., et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 86 (1989) 407-412
23. Ford S.E., Charette E.J.P., Knight J., et al. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 17 (1990) 1499-1503
24. Hojnik M., George J., Ziporen L., and Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93 (1996) 1579-1587
25. Ziporen L., Goldberg I., Arad M., et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5 (1996) 196-205
26. Vianna J.L., Khamashta M.A., Ordi-Ros J., et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 96 (1994) 3-9
27. Perez-Villa F., Font J., Azqueta M., et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow up study. Arthritis Rheum 53 (2005) 460-467
28. Galve E., Candell-Riera J., Pigrau C., et al. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319 (1988) 817-823
29. Roldan C., Shively B., and Crawford M. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335 (1996) 1424-1430
30. Asherson R.A., and Lubbe W.F. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol 15 (1988) 539-543
31. Barbut D., Borer J., Wallerson D., and Lockshin M. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology 79 (1991) 99-109
32. Joven B., Mellor-Pita S., D'Cruz D., et al. Cerebral embolism complicating Libman-Sacks endocarditis-full recovery using recombinant tissue plasminogen activator. J Rheumatol 29 (2002) 2022-2024